CD274 and cancer: Recently, the PD-1/PD-L1 pathway has become the subject of extensive research in cancer immunotherapy, as PD-1/PD-L1 antibody blockade has demonstrated efficacy in inducing cell-mediated immunity against multiple cancer types.